Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jul;51(7):870-872.
doi: 10.1111/cea.13904. Epub 2021 Jun 11.

Are biologics for chronic rhinosinusitis effective and safe?

Anjali Rampersad  1 , Nandini Banerjee  2 , Timothy S C Hinks  3
Affiliations
Editorial

Are biologics for chronic rhinosinusitis effective and safe?

Anjali Rampersad et al. Clin Exp Allergy. 2021 Jul.

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] Clin Exp Allergy. 2022 Jan;52(1):209. doi: 10.1111/cea.13996. Clin Exp Allergy. 2022. PMID: 34978738 No abstract available.
No abstract available

PubMed Disclaimer

Comment on

  • Biologics for chronic rhinosinusitis.
    Chong LY, Piromchai P, Sharp S, Snidvongs K, Webster KE, Philpott C, Hopkins C, Burton MJ. Chong LY, et al. Cochrane Database Syst Rev. 2021 Mar 12;3(3):CD013513. doi: 10.1002/14651858.CD013513.pub3. Cochrane Database Syst Rev. 2021. PMID: 33710614 Free PMC article.

References

REFERENCES

    1. Sedaghat AR. Chronic rhinosinusitis. Infections of the Ears, Nose, Throat, and Sinuses. 2018:155-168.
    1. Patel GB, Peters AT. The role of biologics in chronic rhinosinusitis with nasal polyps. Ear Nose Throat J. 2021;100(1):44-47.
    1. Grundmann SA, Hemfort PB, Luger TA, Brehler R. Anti-IgE (omalizumab): a new therapeutic approach for chronic rhinosinusitis. J Allergy Clin Immunol. 2008;121(1):257.
    1. Philpott C, Hopkins C, Erskine S, et al. The burden of revision sinonasal surgery in the UK--data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study. BMJ Open. 2015;5(4):e006680. https://doi.org/10.1136/bmjopen-2014-006680
    1. Joint Formulary Committee. British National Formulary (online). London: BMJ Group and Pharmaceutical Press. http://www.medicinescomplete.com. Accessed on 11th May; 2021.

Substances

LinkOut - more resources